The Vaccine – is it all Over?

On 9 November 2020, BioNTech/Pfizer announced that they had developed a vaccine which was effective in preventing 90% of people from contracting covid-19. At the conclusion of Phase 3 trails on 43,000 people, they declared ...

Covid and the Global South

While the course of the pandemic in Europe and America has been afforded blanket coverage, its potentially far greater impact on the Global South has received far less attention. Yet in the number of cases ...